A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis

Local Institution - 0013, Hohhot

Local Institution - 0017, Wenzhou

Local Institution - 0009, Beijing

Local Institution - 0002, Beijing

Local Institution - 0021, Shenyang

Local Institution - 0005, Changchun

Local Institution - 0006, Harbin

Local Institution - 0016, Shanghai

Local Institution - 0014, Shanghai

Local Institution - 0001, Tianjin

Local Institution - 0019, Hangzhou

Local Institution - 0003, Nanchang

Local Institution - 0025, Fuzhou

Local Institution - 0007, Wuhan

Local Institution - 0018, Zhengzhou

Local Institution - 0012, Guangzhou

Local Institution - 0022, Guangzhou

Local Institution - 0008, Shenzhen

Local Institution - 0010, Guiyang

Local Institution - 0011, Chengdu

Local Institution - 0024, Kunming

Local Institution - 0020, Xianyang

Local Institution - 0023, Ürümqi

Local Institution - 0004, Shijiazhuang

Local Institution - 0015, Taiyuan